We are live on ! Find out more
AVA

Atlas Venture Advisors Portfolio holdings

AUM $122M
1-Year Est. Return 26.28%
This Fund
S&P 500
This Quarter Est. Return
+18.21%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
AUM
$73.9M
AUM Growth
+$7.67M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 83.7%
2 Communication Services 10.79%
3 Technology 5.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBIO
1
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$39.1M 52.94%
3,922,008
BCYC
2
Bicycle Therapeutics
BCYC
$270M
$18.6M 25.18%
1,362,696
ROKU icon
3
Roku
ROKU
$21.1B
$5.05M 6.83%
57,707
DDOG icon
4
Datadog
DDOG
$87.9B
$4.07M 5.52%
113,232
SNAP icon
5
Snap
SNAP
$7.32B
$2.92M 3.95%
245,559
LRMR icon
6
Larimar Therapeutics
LRMR
$416M
$2.7M 3.66%
292,184
VRDN icon
7
Viridian Therapeutics
VRDN
$2.13B
$1.41M 1.91%
209,505

Similar funds

Atlas Venture Advisors's Q1 2020 Portfolio in Review

As of Q1 2020, Atlas Venture Advisors held 7 positions worth $73.9M, up 12% from $66.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 0%. Atlas Venture Advisors opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 76% a quarter earlier, followed by Communication Services and Technology.

  • Atlas Venture Advisors's ten largest holdings make up 100% of its $73.9M portfolio in Q1 2020.
  • Atlas Venture Advisors opened 0 new positions and closed 0 in Q1 2020.
  • Atlas Venture Advisors's portfolio value rose 12% quarter-over-quarter to $73.9M.

Based on Atlas Venture Advisors's 13F filing for Q1 2020, filed 7 May 2020.